... Herpes Simplex Virus (HSV) infection. In a specific embodiment of the ... Virus Type 2 (HSV-2), which commonly causes genital herpes. The time of ...

1 depicts plaque-forming activities per viral genome for isolates 1-4, parent virus K26-gD:2/3NI, and control K26GFP on B78H1 cells and derivatives expressing ...

1 depicts plaque-forming activities per viral genome for isolates 1-4, parent virus K26-gD:2/3NI, and control K26GFP on B78H1 cells and derivatives expressing ...

US9593347B2 - Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV ...

More rarely, the infection takes the form of a serious corneal, encephalitic or systemic disease. Type I Herpes simplex viral infections generally are ...

Provided herein are Vero cell lines that stably express Herpes Simplex Virus (HSV) ICP0 protein. ... A viral plaque is formed when a virus infects a cell within ...

The present invention provides a method of inhibiting the formation of infectious herpes virus particles, particularly infectious herpes simplex virus (HSV) ...

9 is a line graph quantifying the replication (expressed as plaque forming units (pfu)/ml) of the indicated viruses (wild-type (WT), Δ34.5ΔICP47, OV-2711 and ...

Herpes simplex infections may also take a more serious form in which the virus travels along nerve cells to the area of the eye socket. Here, HSV may cause ...

form. Active phase herpes lesions are wetted with the benzalkonium ... Recurrent viral infection by herpes simplex virus, also known as Herpesvirus ...

Jun 15, 2013 ... Herpes simplex virus type 1 (HSV-1) causes a latent infection in the trigeminal ganglion (TG) that hovers between acute and chronic disease.

a method of treating cancer in a subject in need of treatment comprising administering an oncolytic herpes simplex virus (HSV) in sufficient quantity and over a ...

... formation in Vero cells infected with HSV-1 virus without affecting cell viability. ... HSV-1 or herpes simplex virus-2 (HSV-2). In other specific embodiments, ...

In addition, portions of the particle-forming protein coding sequence may be replaced with codons encoding an HSV VP16 or HSV glycoprotein epitope. In this ...

The present invention provides a method of inhibiting the formation of infectious herpes virus particles, particularly infectious herpes simplex virus (HSV) ...

Herpes simplex virus (HSV) is a DNA virus capable of rapidly and efficiently ... Helper virus titers (pfu/ml; plaque-forming units/ml), amplicon ...

... infection with Herpes simplex virus type 1 and/or 2. The active substance is represented by the synthetic zeolites in pure form, with defined crystal ...

Aug 3, 2022 ... ... zoster virus (VZV), which causes ... Zoster Virus in Alzheimer's Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1.

8 is a table summarizing the results of the plaque formation, cell to cell spread, and HSV entry assays of the invention for region IV variant gD-1 molecules of ...

An oncolytic herpes simplex virus is disclosed for use in a method of treating primary liver cancer.